Strategic Initiative

Slingshot members are tracking this corporate initiative:

Teva (TEVA) and Regeneron (REGN) Agree to Global Commercialization and Development Deal for REGN's Fasinumab in Chronic Lower Back Pain

Source Link:: https://www.sec.gov/Archives/edgar/data/818686/000130901416001317/exhibit1.htm

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

100%

100%

Strategic Initiative Date

Announcement Date:

Sep 20, 2016

Projected Implementation:

Q4, 2016

Relevance Tracked Until:

Q4, 2018

Related Projects

Related Keywords Global Partnership, Commercialization, Development, Fasinumab, Chronic Lower Back Pain